Gene · 990
Papers3,285
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,285
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ikaros Regulates microRNA Networks in Acute Lymphoblastic Leukemia. | Epigenomes | 2022 | 36278683 | PubTator, text mining | PubMed |
| The oncogenic role of SNRPB in human tumors: A pan-cancer analysis. | Front Mol Biosci | 2022 | 36275630 | PubTator, text mining | PubMed |
| Therapeutic resistance in acute myeloid leukemia cells is mediated by a novel ATM/mTOR pathway regulating oxidative phosphorylation. | Elife | 2022 | 36259537 | PubTator, text mining | PubMed |
| LCAT1 is an oncogenic LncRNA by stabilizing the IGF2BP2-CDC6 axis. | Cell Death Dis | 2022 | 36257938 | PubTator, text mining | PubMed |
| GPI: An indicator for immune infiltrates and prognosis of human breast cancer from a comprehensive analysis. | Front Endocrinol (Lausanne) | 2022 | 36246907 | PubTator, text mining | PubMed |
| Histone lysine methylation patterns in prostate cancer microenvironment infiltration: Integrated bioinformatic analysis and histological validation. | Front Oncol | 2022 | 36237332 | PubTator, text mining | PubMed |
| Safeguarding DNA Replication: A Golden Touch of MiDAS and Other Mechanisms. | Int J Mol Sci | 2022 | 36232633 | PubTator, text mining | PubMed |
| A Novel Strategy for Identifying NSCLC MicroRNA Biomarkers and Their Mechanism Analysis Based on a Brand-New CeRNA-Hub-FFL Network. | Int J Mol Sci | 2022 | 36232605 | PubTator, text mining | PubMed |
| Evaluation of the Synergistic Potential of Simultaneous Pan- or Isoform-Specific BET and SYK Inhibition in B-Cell Lymphoma: An In Vitro Approach. | Cancers (Basel) | 2022 | 36230614 | PubTator, text mining | PubMed |
| Construction of novel lncRNA-miRNA-mRNA ceRNA networks associated with prognosis of hepatitis C virus related hepatocellular carcinoma. | Heliyon | 2022 | 36217480 | PubTator, text mining | PubMed |
| Long-range phasing of dynamic, tissue-specific and allele-specific regulatory elements. | Nat Genet | 2022 | 36195755 | PubTator, text mining | PubMed |
| CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma. | Oxid Med Cell Longev | 2022 | 36193067 | PubTator, text mining | PubMed |
| HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans. | Clin Cancer Res | 2022 | 36190432 | PubTator, text mining | PubMed |
| Identification and verification of hub genes associated with the progression of non-small cell lung cancer by integrated analysis. | Front Pharmacol | 2022 | 36176446 | PubTator, text mining | PubMed |
| Transcriptome Sequencing Analysis of the Effect of β-Elemene on Colorectal Cancer from the lncRNA-miRNA-mRNA Perspective. | Genet Res (Camb) | 2022 | 36160034 | PubTator, text mining | PubMed |
| Convolutional-de-convolutional neural networks for recognition of surgical workflow. | Front Comput Neurosci | 2022 | 36157842 | PubTator, text mining | PubMed |
| Cross-GWAS coherence test at the gene and pathway level. | PLoS Comput Biol | 2022 | 36156592 | PubTator, text mining | PubMed |
| Berberine: An Important Emphasis on Its Anticancer Effects through Modulation of Various Cell Signaling Pathways. | Molecules | 2022 | 36144625 | PubTator, text mining | PubMed |
| MC180295 Inhibited Epstein-Barr Virus-Associated Gastric Carcinoma Cell Growth by Suppressing DNA Repair and the Cell Cycle. | Int J Mol Sci | 2022 | 36142506 | PubTator, text mining | PubMed |
| Bioinformatics Identification of TUBB as Potential Prognostic Biomarker for Worse Prognosis in ERα-Positive and Better Prognosis in ERα-Negative Breast Cancer. | Diagnostics (Basel) | 2022 | 36140469 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/990/papers?page=24